 Connection
Linda Cook to Prospective Studies
This is a "connection" page, showing publications Linda Cook has written about Prospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.215 |
|
|
|
-
Friedenreich CM, Derksen JWG, Speidel T, Brenner DR, Heer E, Courneya KS, Cook LS. Case-control study of endogenous sex steroid hormones and risk of endometrial cancer. Cancer Causes Control. 2020 Feb; 31(2):161-171.
Score: 0.064
-
Kokts-Porietis RL, O'Sullivan DE, Nelson G, Courneya KS, Cook LS, Friedenreich CM. Risk factors for second primary cancer in a prospective cohort of endometrial cancer survivors: an Alberta Endometrial Cancer Cohort Study. Am J Epidemiol. 2024 12 02; 193(12):1701-1711.
Score: 0.022
-
Gai X, Feng Y, Flores TM, Kang H, Yu H, Leslie KK, Zhu Y, Doherty JA, Guo Y, Belinsky SA, Cook LS, Leng S. Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial. Thorax. 2024 09 18; 79(10):961-969.
Score: 0.022
-
Kokts-Porietis RL, Morielli AR, McNeil J, Benham JL, Courneya KS, Cook LS, Friedenreich CM. Prospective cohort of pre- and post-diagnosis alcohol consumption and cigarette smoking on survival outcomes: an Alberta Endometrial Cancer Cohort Study. Cancer Causes Control. 2024 Jan; 35(1):121-132.
Score: 0.021
-
Kokts-Porietis RL, Morielli AR, McNeil J, Courneya KS, Cook LS, Friedenreich CM. Prospective Cohort of Pre- and Post-Diagnosis Diet with Survival Outcomes: an Alberta Endometrial Cancer Cohort Study. Cancer Epidemiol Biomarkers Prev. 2023 02 06; 32(2):242-251.
Score: 0.020
-
Kokts-Porietis RL, McNeil J, Morielli AR, Cook LS, Courneya KS, Friedenreich CM. Prospective Cohort Study of Pre- and Postdiagnosis Obesity and Endometrial Cancer Survival. J Natl Cancer Inst. 2022 03 08; 114(3):409-418.
Score: 0.019
-
Morielli AR, Kokts-Porietis RL, Benham JL, McNeil J, Cook LS, Courneya KS, Friedenreich CM. Associations of insulin resistance and inflammatory biomarkers with endometrial cancer survival: The Alberta endometrial cancer cohort study. Cancer Med. 2022 04; 11(7):1701-1711.
Score: 0.019
-
Lorona NC, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI. Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer. Cancer Causes Control. 2021 Dec; 32(12):1375-1384.
Score: 0.018
-
Brockton NT, Gill SJ, Laborge SL, Paterson AH, Cook LS, Vogel HJ, Shemanko CS, Hanley DA, Magliocco AM, Friedenreich CM. The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer. BMC Cancer. 2015 Jul 10; 15:512.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|